Premium
Acceptance of Naltrexone by Pregnant Women Enrolled in Comprehensive Drug Addiction Treatment: An Initial Survey
Author(s) -
Jones Hendrée E.
Publication year - 2012
Publication title -
the american journal on addictions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.997
H-Index - 76
eISSN - 1521-0391
pISSN - 1055-0496
DOI - 10.1111/j.1521-0391.2012.00229.x
Subject(s) - naltrexone , medicine , heroin , addiction , population , psychiatry , pregnancy , narcotic antagonist , antagonist , drug , receptor , environmental health , biology , genetics
This paper reports the results of an initial survey regarding the potential interest in naltrexone treatment by pregnant women enrolled in comprehensive treatment for substance use disorders. Pregnant women (N = 112) were asked about their interest in taking either an oral or long‐acting injectable medication that would stop heroin and/or alcohol use, leave them “clear‐headed,” and without neonatal withdrawal. Results indicate strong interest among pregnant women in antagonist treatment, in either form, with clear interest in learning more about naltrexone. Findings lend support for patient's acceptance of a clinical trial of antagonist treatment in this population. (Am J Addict 2012;21:199–201)